[1] WHO. Global hepatitis report 2017[EB/OL].[2018-01-10]http://www. who. int/hepatitis/publications/global-hepatitis-report2017/en/.
|
[2] WU XF,LI YF,ZHANG C,et al. Influencing factors for compliance with antiviral therapy with nucleos(t)ide analogues in patients with chronic hepatitis B[J]. J Clin Hepatol,2019,35(10):2194-2199.(in Chinese)吴小凤,李玉芳,张驰,等.慢性乙型肝炎患者核苷(酸)类似物抗病毒治疗依从性的影响因素分析[J].临床肝胆病杂志,2019,35(10):2194-2199.
|
[3] CHOTIYAPUTTA W,OBERHELMAN K,HONGTHANAKORN C,et al. Correlation between self-reported adherence to nucleos(t)ide analog(NUC)therapy for chronic hepatitis B and virological breakthroughs(VBT). AASLD[J]. Hepatology,2010,52:542A.
|
[4] Chinese Society of Hepatology,Chinese Medical Association.Chinese Society of Infectious Diseases,Chinese Medical Association; The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J]. J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会.中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.
|
[5] PETERSON AM,NAU DP,CRAMER JA,et al. A checklist for medication compliance and persistence studies using retrospective databases[J]. Value Health,2007,10(1):3-12.
|
[6] LUMLEY T,KRONMAL R,MA S. Relative risk regression in medical research:Models,contrasts,estimators,and algorithms[R]. Bepress,2006:293.
|
[7] QIU Q. Effect of the partial reimbursement implementation of antivirals for hepatitis B virus in Beijing:Comparative effectiveness analysis and cost-effectiveness analysis based on a retrospective cohort study[D]. Beijing:Peking Union Medical College,2015.(in Chinese)邱倩.北京市新医疗保险政策实施后慢性乙型肝炎病人不同抗病毒治疗方案比较效果研究及卫生经济学评价[D].北京:北京协和医学院,2015.
|
[8] ZHANG LM,SHA L,LI NN,et al. Treatment compliance and its influencing factors in patients with chronic hepatitis B[J].Mod Med J,2016,44(1):7-10.(in Chinese)张利漫,沙莉,李楠楠,等.慢性乙型肝炎患者治疗依从性现状及其影响因素分析[J].现代医学,2016,44(1):7-10.
|
[9] SHUBBER Z,MILLS EJ,NACHEGA JB,et al. Patient-reported barriers to adherence to antiretroviral therapy:A systematic review and meta-analysis[J]. PLo S Med, 2016,13:e1002183.
|
[10] HUA L,SHI J,SHA L,et al. Using health belief model education to improve the treatment compliance of patients with chronic hepatitis B[J]. J Clin Med Pract,2014,18(22):124.(in Chinese)华琳,史洁,沙莉,等.运用健康信念模式教育提高慢性乙型肝炎患者治疗依从性的研究[J].实用临床医药杂志,2014,18(22):124.
|
[11] LU SJ,LI Z. Effect of the application of we chat platform on the treatment compliance and satisfaction of chronic hepatitis B patients[J]. Hosp Admin J Chin PLA,2016,23(7):668-670.(in Chinese)鲁松景,李珍.基于微信平台增强慢性乙型肝炎患者的治疗依从性和满意度[J].解放军医院管理杂志,2016,23(7):668-670.
|
[12] KAN Q,WEN J,XUE R. Discrimination against people with hepatitis B in China[J]. Lancet,2015,386(9990):245-246.
|